MedTrace Logo

Electrode-Based Sensor for Non-Invasive Fetal Heart Rate Monitoring With Improved Reliability

NCT02024165 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2015-05-12

Study results available
· View outcomes & findings →

Summary

The specific goal of the proposed research is to develop a reliable, non-invasive fetal and maternal heart rate and contraction monitor that is unaffected by obesity and requires less nursing intervention than the tocodynamometer and Doppler ultrasound.

Conditions

  • Laboring Women With Ultrasound and FSE Monitoring

Sponsors & Collaborators

  • OBMedical Company

    lead OTHER

Principal Investigators

  • John Busowski, MD · Winnie Palmer Hospital for Women and Babies

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02024165 on ClinicalTrials.gov